Home
/ Ainos
/ Competitors

Ainos Competitors and Similar CompaniesClear all

Ainos's competitors and similar companies include Zikani Therapeutics, Sentien Biotechnologies, Entera Bio and CiVi Biopharma.

	Ainos Ainos (formerly known as Amarillo Biosciences) is a healthcare company that specializes in the development of novel biopharmaceuticals, medical treatments, and specialty consumer products.	Zikani Therapeutics Zikani Therapeutics is a company that develops antibiotic compounds created to improve the lives of patients suffering from serious infections.	Sentien Biotechnologies Sentien Biotechnologies is a biotechnology company developing cell therapies to restore balance to the immune system.	Entera Bio Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel drug delivery platform.	CiVi Biopharma CiVi Biopharma is a clinical-stage research and development biotechnology company.
Founding Date	Founding Date 1984	Founding Date 2015	Founding Date 2008	Founding Date 2010	Founding Date 2016
Type	Type Public	Type Subsidiary	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech diabetes drug development pharma therapy	Tags Healthcare biotech drug development healthtech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech clinical research pharma
Locations	Locations Amarillo, US HQ Taipei, TW	Locations Watertown, US HQ	Locations Lexington, US HQ	Locations Wellesley, US HQ Jerusalem, IL	Locations Chevy Chase, US HQ Conshohocken, US
Employees	Employees 4326% increase	Employees 13	Employees 517% decrease	Employees 1616% decrease	Employees 8
Valuation ($)	Valuation ($) 4.4 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 68.7 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $124.2k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $42k (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $21.2k (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods $42k (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $102.9k (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 12m (about 9 years ago)	Latest funding round N/A	Latest funding round $ 49m (almost 8 years ago)
Total funding raised	Total funding raised N/A	Total funding raised $ 7.5m	Total funding raised $ 15.1m	Total funding raised N/A	Total funding raised $ 89m